Cezary Watala

Summary

Affiliation: University of Lodz
Country: Poland

Publications

  1. ncbi Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets
    Cezary Watala
    Laboratory of Haemostatic Disorders, Medical University of Łódź, Łódź, Poland
    Cytometry 49:119-33. 2002
  2. ncbi Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin
    Cezary Watala
    Department of Hemostasis and Hemostatic Disorders, Medical University of Lodz, ul Zeromskiego 113, 90 549 Lodz, Poland
    J Mol Med (Berl) 83:148-58. 2005
  3. ncbi Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control
    Cezary Watala
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz ul, Zeromskiego 113 90 549 Lodz, Poland
    Thromb Res 113:101-13. 2004
  4. ncbi Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus
    Cezary Watala
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, Poland
    Curr Pharm Des 11:2331-65. 2005
  5. ncbi Targeting the urine and plasma determinants of thromboxane A2 metabolism in detection of aspirin effectiveness
    Marcin Dobaczewski
    Department of Hemostasis and Hemostatic Disorders, Medical University of Lodz, University Hospital No 2, Lodz, Poland
    Blood Coagul Fibrinolysis 19:421-8. 2008
  6. ncbi Elevated cholesterol reduces acetylsalicylic acid-mediated platelet acetylation
    Magdalena Boncler
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, Medical University Hospital No 2, 113 Zeromskiego Street, 90 549 Lodz, Poland
    Biochim Biophys Acta 1770:1651-9. 2007
  7. ncbi Usefulness of whole blood aggregometry and its comparison with thromboxane generation assay in monitoring acetylsalicylic acid effectiveness--a multiparametric study in rats
    Marek Nocun
    Department of Hemostasis and Hemostatic Disorders, Medical University of Lodz, University Hospital No. 2, Lodz, Poland
    Clin Chem Lab Med 44:853-62. 2006
  8. ncbi Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein
    Magdalena Boncler
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, Medical University Hospital No 2, 113 Zeromskiego Street, 90 549 Lodz, Poland
    Thromb Res 119:209-16. 2007
  9. ncbi High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study
    Cezary Watala
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, University Hospital No 2, Lodz, Poland
    Blood Coagul Fibrinolysis 17:113-24. 2006
  10. ncbi The effect of a platelet cholesterol modulation on the acetylsalicylic acid-mediated blood platelet inhibition in hypercholesterolemic patients
    Boguslawa Luzak
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, Poland
    Eur J Pharmacol 658:91-7. 2011

Collaborators

Detail Information

Publications38

  1. ncbi Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets
    Cezary Watala
    Laboratory of Haemostatic Disorders, Medical University of Łódź, Łódź, Poland
    Cytometry 49:119-33. 2002
    ..Platelet activation leads to the loss of a natural asymmetry of membrane phospholipids (PL) and the subsequent exposure of negatively charged PL in platelets with procoagulant activity that can be monitored routinely with annexin V (AN-V)...
  2. ncbi Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin
    Cezary Watala
    Department of Hemostasis and Hemostatic Disorders, Medical University of Lodz, ul Zeromskiego 113, 90 549 Lodz, Poland
    J Mol Med (Berl) 83:148-58. 2005
    ....
  3. ncbi Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control
    Cezary Watala
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz ul, Zeromskiego 113 90 549 Lodz, Poland
    Thromb Res 113:101-13. 2004
    ..Thus, our findings strongly support the requirements for an excellent near-normal metabolic control and may suggest a need for alternative ASA dosing schedules in DM patients...
  4. ncbi Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus
    Cezary Watala
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, Poland
    Curr Pharm Des 11:2331-65. 2005
    ..Observations from clinical studies rather support the use of multifactorial strategy under such circumstances, like a combined therapy of aspirin plus either purinoreceptor blocker or GPIIb-IIIa antagonist...
  5. ncbi Targeting the urine and plasma determinants of thromboxane A2 metabolism in detection of aspirin effectiveness
    Marcin Dobaczewski
    Department of Hemostasis and Hemostatic Disorders, Medical University of Lodz, University Hospital No 2, Lodz, Poland
    Blood Coagul Fibrinolysis 19:421-8. 2008
    ....
  6. ncbi Elevated cholesterol reduces acetylsalicylic acid-mediated platelet acetylation
    Magdalena Boncler
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, Medical University Hospital No 2, 113 Zeromskiego Street, 90 549 Lodz, Poland
    Biochim Biophys Acta 1770:1651-9. 2007
    ..The molecular basis of such an association remains obscure, notwithstanding it may constitute a link between sub-optimal platelet response to aspirin and lipid metabolic disorders...
  7. ncbi Usefulness of whole blood aggregometry and its comparison with thromboxane generation assay in monitoring acetylsalicylic acid effectiveness--a multiparametric study in rats
    Marek Nocun
    Department of Hemostasis and Hemostatic Disorders, Medical University of Lodz, University Hospital No. 2, Lodz, Poland
    Clin Chem Lab Med 44:853-62. 2006
    ..CONCLUSIONS: Analysis of aggregation curves, routinely based only on the amplitude and rate of platelet aggregation, may not be enough discriminative to distinguish between varying ASA doses and treatment schedules...
  8. ncbi Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein
    Magdalena Boncler
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, Medical University Hospital No 2, 113 Zeromskiego Street, 90 549 Lodz, Poland
    Thromb Res 119:209-16. 2007
    ..Thus, we conclude that the effectiveness of aspirin therapy may strongly depend upon the presence of native CRP in circulation...
  9. ncbi High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study
    Cezary Watala
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, University Hospital No 2, Lodz, Poland
    Blood Coagul Fibrinolysis 17:113-24. 2006
    ..Our data validate the suggestion that the relationship between aspirin ineffectiveness and poor metabolic control, first revealed in humans, concerns also other animals' platelets and holds regardless of the model or type of diabetes...
  10. ncbi The effect of a platelet cholesterol modulation on the acetylsalicylic acid-mediated blood platelet inhibition in hypercholesterolemic patients
    Boguslawa Luzak
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, Poland
    Eur J Pharmacol 658:91-7. 2011
    ..This effect may extend beyond the action of atorvastatin as merely a lipid-lowering agent. The mechanisms of resistance of some patients to such a combined ASA-statin treatment remain to be elucidated...
  11. ncbi Effectiveness of modified C-reactive protein in the modulation of platelet function under different experimental conditions
    Magdalena Boncler
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, University Hospital No 2, 113 Zeromskiego Street, Lodz, Poland
    Blood Coagul Fibrinolysis 22:301-9. 2011
    ..Taken together, the modulation of platelet function by mCRP seems to be strongly determined by the presence of the gamma globulin fraction in platelet milieu...
  12. ncbi Increased blood plasma hydrolysis of acetylsalicylic acid in type 2 diabetic patients: a role of plasma esterases
    Peter Gresner
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, Zeromskiego 113, 90 549 Lodz, Poland
    Biochim Biophys Acta 1760:207-15. 2006
    ..01). No direct effects of plasma pH or albumin were observed. In conclusion, higher aspirin esterase activity contributes to the lowered response of diabetic platelets to ASA-mediated antiplatelet therapy...
  13. ncbi Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Leszek Markuszewski
    Department of Interventional Cardiology, Cardiodiabetology and Cardiac Rehabilitation, Medical University of Lodz, University Hospital No. 2, Lodz, Poland
    Basic Clin Pharmacol Toxicol 98:503-9. 2006
    ..Dyslipidaemia and chronic inflammatory states may promote suboptimal acetylsalicylic acid response in coronary artery disease patients...
  14. ncbi Blood platelet abnormalities and pharmacological modulation of platelet reactivity in patients with diabetes mellitus
    Cezary Watala
    Department of Haemostasis and Haemostatic Disorders, Medical University of Łódź, Zeromskiego 113, PL 90 549 Łódź, Poland
    Pharmacol Rep 57:42-58. 2005
    ..Although we are at the very beginning of complete understanding of so-called 'aspirin-resistance', several potential molecular mechanisms of this phenomenon in diabetes have been evidenced...
  15. ncbi French maritime pine bark extract Pycnogenol reduces thromboxane generation in blood from diabetic male rats
    Marek Nocun
    Department of Hemostasis and Hemostatic Disorders, Medical University of Lodz, University Hospital No 2, 90 549 Lodz, Poland
    Biomed Pharmacother 62:168-72. 2008
    ..The results of the present study suggest that Pycnogenol might have a beneficial antithrombotic effect when administered alone or as a supplementation of standard antiplatelet therapy in diabetic patients...
  16. ncbi Limited usefulness of the PFA-100 for the monitoring of ADP receptor antagonists--in vitro experience
    Jacek Golanski
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, Lodz, Poland
    Clin Chem Lab Med 42:25-9. 2004
    ..The outcomes of this study show that platelet aggregometry in whole blood is characterised by the highest sensitivity in the monitoring of the investigated blood platelet inhibitors...
  17. ncbi Effect of the 807 c/t polymorphism in glycoprotein ia on blood platelet reactivity
    Boguslawa Luzak
    Department of Hemostasis and Hemostatic Disorders, , ul. Narutowicza 96, , Poland
    J Biomed Sci 10:731-7. 2003
    ..Our results indicate that the 807 T/T genotype is related to increased platelet activation induced by ADP and higher platelet sensitivity to GPIaIIa antagonists...
  18. ncbi Is platelet aggregation a more important contributor than platelet adhesion to the overall platelet-related primary haemostasis measured by PFA-100?
    Cezary Watala
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, Poland
    Thromb Res 109:299-306. 2003
    ..The inputs of platelet aggregation and platelet adhesion into the real values of CT remain unknown, and this poor discrimination results in the complexity of the PFA-100 measurement...
  19. ncbi Resorcylidene aminoguanidine induces antithrombotic action that is not dependent on its antiglycation activity
    Cezary Watala
    Department of Haemostasis and Haemostatic Disorders, Chair of Laboratory Diagnostics, Medical University of Lodz, University Hospital No 2, Lodz, Poland
    Vascul Pharmacol 51:275-83. 2009
    ..Our results indicate that designing novel RAG derivatives with optimal antithrombotic and antiglycation activities may prove useful to treat diabetic complications...
  20. ncbi 1-methylnicotinamide effects on the selected markers of endothelial function, inflammation and haemostasis in diabetic rats
    Tomasz Przygodzki
    Department of Haemostasis and Haemostatic Disorders, Chair of Laboratory Diagnostics, Medical University of Lodz, University Clinical Hospital No 2, Lodz, Poland
    Eur J Pharmacol 640:157-62. 2010
    ..Still other potential mechanism(s) await further elucidation...
  21. ncbi Inhibition of collagen-induced platelet reactivity by DGEA peptide
    Boguslawa Luzak
    Department of Haemostasis and Haemostatic Disorders, , dz, Poland
    Acta Biochim Pol 50:1119-28. 2003
    ....
  22. ncbi Genetic factors underlying differential blood platelet sensitivity to inhibitors
    Marcin Rozalski
    Department of Hemostasis and Hemostatic Disorders, , Zeromskiego 113, , Poland
    Pharmacol Rep 57:1-13. 2005
    ..Additionally, a potential role of 807C/T polymorphism (GPIa), polymorphisms of GPIb and platelet purinoreceptor P2Y12 in affecting platelet sensitivity to blocking agents is discussed...
  23. ncbi [Role of C-reactive protein in atherogenesis]
    Magdalena Boncler
    Zakład Zaburzeń Krzepniecia Krwi, Uniwersytet Medyczny w Łodzi, Łódź, Poland
    Postepy Hig Med Dosw (Online) 60:538-46. 2006
    ....
  24. ncbi Effect of poly(amido)amine (PAMAM) G4 dendrimer on heart and liver mitochondria in an animal model of diabetes
    Magdalena Labieniec
    Department of General Biophysics, University of Lodz, 12 16 Banacha Street, 90 237 Lodz, Poland
    Cell Biol Int 34:89-97. 2010
    ..Thus ameliorating effects of PAMAM G4 on glycation and glycoxidation in experimental diabetes are not sufficient to restore the impaired mitochondrial function in diabetes...
  25. ncbi Use of poly(amido)amine dendrimers in prevention of early non-enzymatic modifications of biomacromolecules
    Magdalena Labieniec
    Department of General Biophysics, University of Lodz, 90 237 Lodz, 12 16 Banacha Street, Poland
    Biochimie 92:1296-305. 2010
    ....
  26. ncbi Effects of resorcylidene aminoguanidine (RAG) on selected parameters of isolated rat liver mitochondria
    Magdalena Labieniec
    Department of General Biophysics, University of Lodz, 12 16 Banacha Str, 90 237 Lodz, Poland
    Chem Biol Interact 179:280-7. 2009
    ....
  27. ncbi Antagonists of platelet fibrinogen receptor are less effective in carriers of Pl(A2) polymorphism of beta(3) integrin
    Marcin Rozalski
    Laboratory of Haemostasis and Haemostatic Disorders, Medical University of Łódź, ul Narutowicza 96, 90 141 Łódź, Poland
    Eur J Pharmacol 454:1-8. 2002
    ..In conclusion, GPIIb-IIIa blockers representing various classes are less effective inhibitors of platelet aggregation in Pl(A2)(+) carriers; however, the effect of the genotype is both agonist- and antagonist-dependent...
  28. ncbi Effect of acetylsalicylic acid on the current-voltage characteristics of planar lipid membranes
    Cezary Watala
    Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, 113 Zeromski str, 90 549 Lodz, Poland
    Biophys Chem 142:27-33. 2009
    ..In conclusion, the effects of ASA on lipid bilayer stability may contribute to drug transport through membrane lipid bilayers...
  29. ncbi Extract from Aronia melanocarpa fruits potentiates the inhibition of platelet aggregation in the presence of endothelial cells
    Boguslawa Luzak
    Department of Haemostasis and Haemostatic Disorders, Medical University Hospital No 2, Medical University of Lodz, Poland
    Arch Med Sci 6:141-4. 2010
    ..In this study we evaluated the ability of AM extract to increase the efficacy of human umbilical vein endothelial cells (HUVECs) to inhibit platelet functions in vitro...
  30. ncbi A comparative assessment of HER2 status in operable breast cancer by real-time RT-PCR and by immunohistochemistry
    Piotr Potemski
    Department of Chemotherapy, Medical University of Łódź, Copernicus Memorial Hospital, Łódź, Poland
    Med Sci Monit 12:MT57-61. 2006
    ..The most commonly used methods for detecting HER2 gene amplification in breast cancer are immunohistochemistry and fluorescence in-situ hybridization. The aim of this retrospective study was to assess HER2 expression by real-time RT-PCR...
  31. ncbi Effects of 1-methylnicotinamide and its metabolite N-methyl-2-pyridone-5-carboxamide on streptozotocin-induced toxicity in murine insulinoma MIN6 cell line
    Tomasz Przygodzki
    Department of Haemostasis and Haemostatic Disorders, Chair of Laboratory Diagnostics, Medical University of Lodz, University Clinical Hospital No 2, Łódź, Poland
    Acta Biochim Pol 58:75-7. 2011
    ..We conclude that inhibition of poly-ADP-ribose polymerase-dependent nucleotide pool reduction may not be sufficient to protect cells from streptozotocin toxicity...
  32. ncbi Cerivastatin, a HMG-CoA reductase inhibitor, reduces plasminogen activator inhibitor-1 (PAI-1) expression in endothelial cells by down-regulation of cellular signaling and the inhibition of PAI-1 promoter activity
    Maria Swiatkowska
    Department of Molecular and Medical Biophysics, Medical University of Lodz, Poland
    Jpn J Pharmacol 90:337-44. 2002
    ....
  33. ncbi Is aspirin resistance a real problem in people with type 2 diabetes?
    Jozef Drzewoski
    Diabetes Care 27:1245-6. 2004
  34. ncbi Phosphatidylserine content is a more important contributor than transmembrane potential to interactions of merocyanine 540 with lipid bilayers
    Iveta Waczulikova
    Department of Biophysics and Chemical Physics, Comenius University, Bratislava, Slovak Republic
    Biochim Biophys Acta 1567:176-82. 2002
    ..In conclusion, the content of negatively charged PL is more important than TMP in determining the interactions of MC540 with PS/PC membranes...
  35. ncbi Blood platelet membrane fluidity and the exposition of membrane protein receptors in Alzheimer disease (AD) patients--preliminary Study
    Wojciech Kozubski
    Department of Neurology, University of Medical Sciences, Poznan, Poland
    Alzheimer Dis Assoc Disord 16:52-4. 2002
    ..0001) and activated (p < 0.005) platelets, as well as the expression of P-selectin and beta 3 subunit of GP IIb/IIIa in activated platelets (p < 0.0001; p < 0.04)...
  36. ncbi Resistance to oral antiplatelet drugs--a Position Paper of the Working Group on antiplatelet drug resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society
    Wiktor Kuliczkowski
    3rd Department of Cardiology, Silesian Center of Heart Diseases, Zabrze
    Kardiol Pol 66:470-6, 480-5; discussion 477-9, 486-7. 2008